NCT03474224View on ClinicalTrials.gov

Hemodynamic Optimization During Major Urological Surgery

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

October 5, 2018

Primary Completion Date

July 21, 2020

Study Completion Date

July 28, 2020

Conditions
Hemodynamic Instability
Interventions
DEVICE

Ev1000 Clinical Platform from Edwards Lifesciences

The EV1000 Hemodynamic monitoring platform will be used to guide fluid administration following a volume-based parameter such the stroke volume.

Trial Locations (1)

00166

Andrea Russo, Rome

All Listed Sponsors
lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER

NCT03474224 - Hemodynamic Optimization During Major Urological Surgery | Biotech Hunter | Biotech Hunter